Biocon Limited
NSE: BIOCON | Information Technology
Market Fundamentals
Stock Intelligence & News
Biocon Ltd (532523)
Communication regarding remittance of final dividend for the FY 2025-26
Read Full Analysis →Biocon Ltd (532523)
Press Release
Read Full Analysis →Biocon Limited
Biocon Limited has informed the Exchange regarding a press release dated September 08, 2026, titled "Biocon Secures 10-Year Supply Contract for Pertuzumab in Brazil". |SUBJECT: Press Release
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Biocon Ltd (532523)
Communication regarding remittance of final dividend for the FY 2025-26
Read Full Analysis →Biocon Ltd (532523)
The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mylan Inc.
Read Full Analysis →Biocon Ltd (532523)
Company Statement
Read Full Analysis →Biocon Limited
Biocon Limited has informed the Exchange regarding 'Company Statement'. |SUBJECT: Updates
Read Full Analysis →Biocon Ltd (532523)
Company Statement
Read Full Analysis →Biocon Limited
Biocon Limited has informed the Exchange regarding 'Company Statement'. |SUBJECT: Updates
Read Full Analysis →Biocon Shares Surge Nearly 3% After Q1 Profit Jumps 350%
Biocon has been steadily gaining over three years.
Read Full Analysis →Get instant alerts when BIOCON breaks news
Join investors who track Biocon Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for BIOCON?
BIOCON is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Biocon Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding BIOCON to your custom watchlist.